CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 4 Option exercise See Remarks acquired 521 shares (option exercise)
- 4 Option exercise Chief Scientific Officer acquired 521 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 521 shares (option exercise)
- 4 Planned sale CEO and President sold 60,000 shares at an average $20.86 ($1,251,727)
- 4 Option exercise Chief Medical Officer acquired 521 shares (option exercise)
- 144 Insider Sale of Securities
- 4 Planned sale CEO and President sold 6,500 shares at $25.79 ($167,641)
- 144 Insider Sale of Securities
- DEF 14A Proxy Proxy Statement
- 4 Option exercise CEO and President acquired 15,000 shares (option exercise)
- 4 Planned sale Chief Financial Officer sold 5,000 shares at $27.17 ($135,864)
- 4 Planned sale See Remarks sold 1,785 shares at $27.32 ($48,765)
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-K/A Report 10-K/A
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
Page 17 of 34 · 672 filings